Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Background. The heat shock protein 90 (HSP90s) family is composed of molecular chaperones composed of four isoforms in humans, which has been widely reported as unregulated in various kinds of cancers. Nevertheless, the role of each HSP90s isoform in prognosis and immune infiltration in distinct subtypes of breast cancer (BRAC) remains unclear. Methods. Public online databases including the Oncomine, UALCAN, Kaplan‐Meier Plotter, Tumor IMmune Estimation Resource (TIMER), Gene Expression Profiling Interactive Analysis (GEPIA), GeneMANIA, and Database for Annotation, Visualization, and Integrated Discovery (DAVID) were integrated to perform bioinformatic analyses and to explore the possible associations among HSP90s gene expression, prognosis, and immune infiltration in BRAC. Results. The mRNA expression of all HSP90s members was elevated in distinct clinical stages and subtypes of BRAC, compared with the normal breast tissue (P < 0.05). Overexpressed HSP90AA1 was associated with poor prognosis, particularly, both short overall survival (OS) and release‐free survival (RFS) in Basal‐like BRAC patients; overexpressed HSP90AB1 and HSP90B1 were both associated with poor RFS in Luminal A BRAC patients, while overexpressed TRAP1 was associated with favorable RFS in Luminal A BRAC patients. Moreover, HSP90s gene expression in BRAC showed correlations with the infiltration of CD8+ T cells, neutrophils, macrophages, and dendritic cells (DCs), as well as the activation of tumor‐associated macrophages (TAMs), DCs, and CD4+ helper T (Th) cells. The underlying mechanisms of HSP90s modulating tumor‐infiltrating immune cells (TIICs) might be related with their functions in antigen processing and presentation, major histocompatibility complex (MHC) binding, and assisting client proteins. Conclusion. This study demonstrated that HSP90s family genes were overexpressed and might be serve as prognostic biomarkers in subtypes of BRAC. It might be a novel breakthrough point of BRAC treatment to regulate immune infiltration in BRAC microenvironment for more effective anticancer immunity through pharmacological intervention of HSP90s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple investigations have revealed that HSP90AB1 facilitates tumorigenesis in a spectrum of cancers, including gastric cancer, breast cancer, non-small cell lung cancer (NSCLC), hepatocellular carcinoma, and head and neck squamous cell carcinoma [13–18].”
From Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer (2024) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 1×
“Despite that mortality has declined by improvements in screening and adjuvant systemic treatments, breast cancer (BRAC) is still the most common cancer and the leading cause of cancer-related death for females worldwide [1, 2].”
BackgroundPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038 · cited 1×
“Despite that mortality has declined by improvements in screening and adjuvant systemic treatments, breast cancer (BRAC) is still the most common cancer and the leading cause of cancer-related death for females worldwide [1, 2].”
BackgroundGEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849 · cited 1×
“Gene Expression Profiling Interactive Analysis (GEPIA) is a database used to analyze RNA-seq data, based on 9,736 tumors and 8,587 normal samples from the TCGA and the GTEx projects [25].”
MethodUALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Chandrashekar, D. S., Bashel, B., Balasubramanya, S. A. H., Creighton, C. J., Ponce-Rodriguez, I., Chakravarthi, B. V. S. K., & Varambally, S. (2017) · Neoplasia · doi:10.1016/j.neo.2017.05.002 · Cited by 6,086 · cited 1×
“The UALCAN database is an interactive web portal for in-depth gene expression analysis using RNA sequencing (RNA-seq) and clinical data from the Cancer Genome Atlas (TCGA) project [22].”
MethodTIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Li, T., Fan, J., Wang, B., Traugh, N., Chen, Q., Liu, J. S., Li, B., & Liu, X. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0307 · Cited by 5,913 · cited 4×
“The UALCAN database is an interactive web portal for in-depth gene expression analysis using RNA sequencing (RNA-seq) and clinical data from the Cancer Genome Atlas (TCGA) project [22].”
BackgroundInfluentialGyörffy, B., Lanczky, A., Eklund, A. C., Denkert, C., Budczies, J., Li, Q., & Szallasi, Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0674-9 · Cited by 4,169 · cited 1×
“The Kaplan-Meier (KM) Plotter is an online database that provides 54,000 gene expression profiles with patients’ survival information in twenty-one kinds of cancers, which harbors gene chip and RNA-seq data from GEO, TCGA, and European Genome-phenome Archive [23].”
BackgroundGoldhirsch, A., Winer, E. P., Coates, A. S., Gelber, R. D., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., Albain, K. S., André, F., Bergh, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt303 · Cited by 3,746
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · cited 1×
“Naive CD4+ T cells can differentiate into several lineages of Th cells, including Th1, Th2, Th17, Treg, and Tfh, distinguished by their patterns of cytokine production and biological functions [48].”
BackgroundThe immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263 · cited 1×
“Since the density, subpopulations, and activity of TIICs could lead to distinct outcomes and therapeutic responses of different subtypes of BRAC [33, 34], relations between HSP90s gene expression and immune infiltration in different subtypes of BRCA were analyzed as well.”
Background
Cited by
Recent advances in heat shock proteins in cancer diagnosis, prognosis, metabolism and treatment
Yang, S., Xiao, H., & Cao, L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112074 · Cited by 121
Chakraborty, A., Mohapatra, S. S., Barik, S., Roy, I., Gupta, B., & Biswas, A. (2023) · Bioscience Reports · doi:10.1042/bsr20220324 · Cited by 53
Zhang, H., Yin, X., Zhang, X., Zhou, M., Xu, W., Wei, Z., Song, C., Han, S., & Han, W. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221118202 · Cited by 40
Shen, L., Huang, H., Li, J., Chen, W., Yao, Y., Hu, J., Zhou, J., Huang, F., & Ni, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199465 · Cited by 38
Intrinsic RIG-I restrains STAT5 activation to modulate antitumor activity of CD8+ T cells
Jiang, X., Lin, J., Shangguan, C., Wang, X., Xiang, B., Chen, J., Guo, H., Zhang, W., Zhang, J., Shi, Y., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci160790 · Cited by 23
Plasma Levels of Heat Shock Protein 90 Alpha Associated With Colorectal Cancer Development
Wei, W., Zhou, J., Chen, L., Liu, H., Zhang, F., Li, J., Ning, S., Li, S., Wang, C., Huang, Y., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.684836 · Cited by 17
“Meanwhile, plasma HSP90α levels were significantly higher than healthy controls in other cancers, but the diagnostic efficiency was insufficient, such as gastric cancer, breast cancer, nasopharyngeal carcinoma and colorectal cancer (Kasanga et al., 2018; Liu et al., 2019; Lin et al., 2020; Zhang et al., 2020).”
BackgroundSkolastika, S., Hanif, N., Ikawati, M., & Hermawan, A. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4172531 · Cited by 17
Hu, Y., Yu, C., Cheng, L., Zhong, C., An, J., Zou, M., Liu, B., & Gao, X. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03314-4 · Cited by 15
“HSP90 family has been widely reported to affect many oncogene pathways and regulate tumor cell growth and survival [18, 33].”
BackgroundBakker, E. Y., Fujii, M., Krstic–Demonacos, M., Demonacos, C., & Alhammad, R. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5306 · Cited by 15
Chen, O., Fu, L., Wang, Y., Jinggui, L., Liu, J., & Wen, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139443 · Cited by 12
HSP90B1 regulates autophagy via PI3K/AKT/mTOR signaling, mediating HNSC biological behaviors
Li, C., Lin, X., & Su, J. (2024) · PeerJ · doi:10.7717/peerj.17028 · Cited by 12
“Beyond its response to heat stress, HSP90B1 plays a significant part in adapting to diverse tumor microenvironmental factors such as glucose deficiency ( Pugh et al., 2022 ), hypoxia ( Byun et al., 2023 ), acidosis ( Boussadia et al., 2018 ), and immune stimulation ( Lin et al., 2020 ).”
BackgroundWang, X., Huang, H., Liu, X., Li, J., Wang, L., Li, L., Li, Y., & Han, T. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1052720 · Cited by 12
“ICD genes, such as CALR, CASP8, P2RX7, MYD88, CD8A, CXCR3, CD4, TNF, ATG5, and HSP90AA1, were found to be abnormally highly expressed in BC samples (Figure 1A).”
InfluentialHE2Gene: image-to-RNA translation via multi-task learning for spatial transcriptomics data
Chen, X., Lin, J., Wang, Y., Zhang, W., Xie, W., Zheng, Z., & Wong, K. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae343 · Cited by 11
“The selected genes—FASN, ACTG1, PTMA, GNAS, and HSP90AB1—have all been previously identified as known cancer biomarkers (Tripathi et al. 2011, Lin et al. 2020, Jiang et al. 2021, Kastora et al. 2022, Zhang et al. 2022).”
BackgroundHe, J., Li, X., Zhou, J., & Hu, R. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-180 · Cited by 11
“…incorporates a comprehensive biological knowledge base and a employs series of analytic tools when extracting biological themes for proteins or genes (20), was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the genes in the key module.”
Rivaldo, R. M., & Chandra, P. (2024) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_49_24 · Cited by 10
“[14] Drug similarity and physicochemical characteristics were also analyzed with α -mangostin fulfilling the Lipinski, Ghose, Veber, and Egen’s rule of five and can therefore be considered a drug-like molecule.”
MethodHuang, M., Chen, L., Ma, X., & Xu, H. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03542-8 · Cited by 9
Pharmacogenomics of intravenous immunoglobulin response in Kawasaki disease
Shrestha, S., Wiener, H. W., Kajimoto, H., Srinivasasainagendra, V., Ledee, D. R., Chowdhury, S., Cui, J., Chen, J. Y., Beckley, M. A., Padilla, L. A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1287094 · Cited by 9
Liu, J., Lin, J., & Chen, L. (2022) · Immunity Inflammation and Disease · doi:10.1002/iid3.735 · Cited by 8
“Then, rHSP40 was used to stimulate the DCs.”
ResultInfluentialPotential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer
Wang, H. F., Chen, Y., Cao, B., & Pei, J. (2024) · Medical Science Monitor · doi:10.12659/msm.943049 · Cited by 6
“Moreover, breast cancer tissues exhibit higher levels of HSP90 a expression when compared to normal non-cancerous tissues [38].”
BackgroundHSP90 inhibitors in cancer immunotherapy: Therapeutic opportunities and challenges
Zhang, C., Nie, W., Tu, Q., Zhang, Y., Zhao, H., & Song, C. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118195 · Cited by 6
Guo, H., Zhang, Y., Ma, H., Gong, P., Shi, Y., Zhao, W., Wang, A., Liu, M., Sun, Z., Wang, F., et al. (2022) · Adipocyte · doi:10.1080/21623945.2022.2048546 · Cited by 5
“[51] showed that high expression of HSP90AA1, HSP90AB1 and HSP90B1 was associated with poor prognosis of breast cancer”
BackgroundMohajershojai, T., Spangler, D., Chopra, S., Frejd, F. Y., Yazaki, P. J., & Nestor, M. (2023) · Cancers · doi:10.3390/cancers15174239 · Cited by 5
LTA4H extensively associates with mRNAs and lncRNAs indicative of its novel regulatory targets
Ren, T., Wang, S., Zhang, B., Zhou, W., Wang, C., Zhao, X., & Feng, J. (2023) · PeerJ · doi:10.7717/peerj.14875 · Cited by 5
“, 2019), and the highly expressed HSP90B1 represents the poor prognosis of many tumors, including breast cancer and lung cancer (Lin et al., 2020; Liu et al., 2019).”
BackgroundLiu, F., Chen, J., Niu, H., Cao, X., Cao, N., Wei, L., Cheng, X., Zhang, S., & Cao, Y. (2026) · Shock · doi:10.1097/shk.0000000000002792 · Cited by 2
“In oncology, high expression correlates with aggressiveness and poor outcomes (50,52).”
Wu, Y., Zhang, C., Zou, L., Chen, Y., Xiao, X., Jiang, Y., & Yang, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1470440/v1 · Cited by 2
Li, N., Xiao, C., Han, S., Lu, M., Chen, Q., Yang, Y., Tang, L., Ren, Z., & Xu, L. (2025) · Cancer Medicine · doi:10.1002/cam4.70227
“Marked by the association with tumor suppressor protein HSP90AB1 43 and reduced expression of the BC risk prognostic markers MMP9 44 and CXCL8 .”
Hu, Y., Yu, C., Cheng, L., Zhong, C., An, J., Zou, M., Liu, B., & Gao, X. (2024) · Figshare · doi:10.6084/m9.figshare.26716720
The Role of Heat Shock Protein 90 (Hsp90) in the Prediction and Diagnosis of Breast Carcinoma
Hadi, H. S. (2026) · International journal of medical science and pharmaceutical research. · doi:10.55677/ijmspr/2026-3050-i107
Yang, X., Li, Y., Zhang, T., He, B., Wang, J., Zhang, S., & Li, M. (2026) · Discover Oncology · doi:10.1007/s12672-026-04585-1
“Specifically, HSP90AA1 and HSP90AB1, as central components of the heat shock protein family, function as essential molecular chaperones that facilitate the folding, stability, and maturation of a wide range of client proteins—many of which are implicated in oncogenic signaling [24].”
Nuaman, T. A., & Fahad, H. M. (2026) · Journal of Pioneering Medical Science · doi:10.47310/jpms2026150219
“Consequently, heat shock protein 90 has also been shown to be highly expressed in many cancers, including breast cancer can also regulate the immune response in the tumor microenvironment, possibly affecting immune cell infiltration and function [6].”
Mathieu, C. (2021) · theses.fr (ABES) · doi:10.70675/22a753dcze788z44dfz8a6az8a41b201d605
Heeran, A. B., Hannon, G., Moran, B., Mhaonaigh, A. U., Passos, V. L., Menon, M. S., Bhardwaj, A., Ravi, N., Reynolds, J., Prina‐Mello, A., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-59243-x
“In line with our results, HSP90AB1 expression is elevated in multiple cancers, including gastric and colorectal cancer, and has been identified as a poor prognostic marker in head and neck squamous cell carcinoma 49 and breast cancer 50 .”
The role of heat shock protein 90 (Hsp90) in the prediction and diagnosis of breast carcinoma
Hadi, H. S. (2026) · Al-Dalmaj Bulletin of Natural Science · doi:10.29350/dbns.v2i2.44
Shen, L., Huang, H., Li, J., Chen, W., Yao, Y., Hu, J., Zhou, J., Huang, F., & Ni, C. (2023) · doi:10.3389/fimmu.2023.1199465.s002
Shrestha, S., Wiener, H. W., Kajimoto, H., Srinivasasainagendra, V., Ledee, D., Chowdhury, S., Cui, J., Chen, J. Y., Beckley, M. A., Padilla, L. A., et al. (2024) · doi:10.3389/fimmu.2023.1287094.s001
Metadata
- Authors
- Lin, T., Qiu, Y., Peng, W., & Peng, L.
- Affiliations
- Guangzhou University of Chinese Medicine (CN)
- Shenzhen Traditional Chinese Medicine Hospital (CN)
- Corresponding author
- Peng, Lisheng
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2020-01
- Volume
- 2020
- Issue
- 1
- Pages
- 2148253-2148253
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC7596464
- OpenAlex
- W3094633644
- Cited by
- 31
- References
- 57
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 3
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- HSP90, Hsp90 isoforms, HSP90AA1, HSP90AB1, HSP90B1, TRAP1, breast cancer, prognostic factors, tumor immune infiltration, tumor microenvironment, basal-like breast cancer, luminal A, CD8+ T cells, tumor-associated macrophages, dendritic cells, neutrophils, antigen processing and presentation, MHC binding, overall survival, recurrence-free survival
- MeSH terms
- Tumor-Associated Macrophages, Atlases as Topic, Breast Neoplasms, Adenocarcinoma, Mucinous, Cell Movement, Dendritic Cells, Female, Humans, Membrane Glycoproteins, Neoplasm Invasiveness, Prognosis, Biomarkers, Tumor, CD4-Positive T-Lymphocytes, Gene Expression Regulation, Neoplastic, Carcinoma, Lobular, CD8-Positive T-Lymphocytes, HSP90 Heat-Shock Proteins, Computational Biology, Databases, Genetic, Carcinoma, Ductal, Molecular Sequence Annotation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.